SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Taus upcoming oncology milestones are driving attention, particularly the completed IMPACT pancreatic-cancer trial enrollment and expected data, alongside further REGAIN glioblastoma updates. Traders are broadly optimistic about the expanding pipeline, while some emphasize that larger datasets are still needed to validate the early results.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys quarterly results, particularly resilient parks performance and improving streaming profitability, have reinforced bullish sentiment and prompted analyst upgrades. Traders remain divided, with some seeing a turnaround while others point to the stocks long stretch of weak, range-bound performance.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is pulling back after a strong run as traders position ahead of earnings, with some wary of recent SaaS-sector weakness and the stocks valuation. Others remain bullish on growth and AI-driven commerce, while security concerns appear in some bearish posts but are not the dominant discussion.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Attention centers on Candels planned Q4 BLA submission for CAN-2409 in localized prostate cancer and upcoming SITC pipeline data. Bulls see the clinical and regulatory milestones as potential catalysts, while skeptics point to the steep decline, CEO share sales, limited transparency, possible dilution and uncertainty about filing timing; some also blame broader biotech weakness and thin trading.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias early third-quarter report and raised full-year revenue guidance are driving attention, with continued LUPKYNIS sales growth supporting the results. Traders are split between viewing the report as solid execution and frustration that the shares fell despite it, compounded by confusion over whether management held an earnings call.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotifys shares are drawing attention after a sharp post-earnings rally despite revenue and EPS misses; traders are focusing on premium subscriber growth, stronger gross margin, and an upbeat fourth-quarter profit outlook. The move has surprised some investors, who question why the stock rose on a mixed report, while bulls see the guidance and improving ad revenue as the more important signals.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

ALAB is drawing attention amid a sharp pullback alongside other AI and semiconductor stocks, with traders citing stretched valuations, broad market pressure, and uncertainty ahead of earnings. The community is split between buyers treating the decline as an opportunity and bears warning that the stock remains overvalued and could fall further.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs large equity and warrant offering, alongside its Elisity acquisition, has put dilution and capital allocation at the center of the discussion as shares have sold off. Bulls see the financing and acquisitions as building a broader quantum platform, while critics question shareholder costs and execution; a Google quantum breakthrough has also lifted sector optimism, though traders disagree on whether that can overcome IONQ-specific concerns.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCath reimbursement could weaken in 2027 has sparked concerns about pricing and CorMedixs largest revenue driver, contributing to a sharp selloff. Traders are divided over the impact: some see a serious commercial risk, while others argue DaVitas outlook is preliminary and point to CMS reimbursement estimates as a reason the reaction may be excessive.

NEAR Protocol (NEAR) is a cryptocurrency launched in 2020. NEAR Protocol has a current supply of 1,310,395,414. The last known price of NEAR Protocol is 4.30157975 USD and is up 6.10 over the last 24 hours. It is currently trading on 688 active market(s) with $1,245,620,491.67 traded over the last 24 hours. More information can be found at https://near.org/.

Near

Traders are watching a governance vote that could make NEAR less inflationary, with some viewing the tokenomics change as a potential catalyst. Sentiment is split: dip-buyers are accumulating, while cautious traders point to Bitcoin-linked weakness and liquidation risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nebius Says It Is ‘Sequencing’ Its Financing After Getting $3.5B From Citi, With Bigger Asset-Backed Loans Still to Come

Equity

The Nvidia-backed company said proceeds will go toward data center development, GPU purchases and general corporate purposes. 


Should You Invest in the First Trust NASDAQ-100-Technology Sector ETF (QTEC)?

Nebius Could Stand Apart In AI Cloud, Says William Blair – Sees Valuation Understating Long-Term Earnings Power

William Blair highlighted Nebius’ infrastructure scale, software capabilities, major customers, and access to capital as factors that could differentiate its AI cloud platform, according to TheFly, 

Is First Trust NASDAQ-100-Technology Sector ETF (QTEC) a Strong ETF Right Now?

XNDU Stock Rises On ASML Deal To Fix Photonic Quantum Chips' Optical Loss Problem

According to CEO Christian Weedbrook, it is the “most important” technical challenge for Xanadu’s photon-based quantum computing architecture.

NBIS Stock Falls After Announcing Its Third Multi-Billion Dollar Convertible Notes Sale in Under a Year

The company plans to use the proceeds to build and expand data centers, invest in its AI cloud platform, and purchase GPUs and other infrastructure.


NBIS Stock Rallies After The Nvidia-Backed Company Lands $775M Debt Deal To Fund AI Buildout

Nebius said the $775 million loan was backed by GPU hardware already deployed in its data centers and cash flows from an existing customer contract.

First Trust Exchange-Traded Fund - First Trust NASDAQ-100 Technology Sector Index Fund

Neutral Sentiment

<ul class="summary-bullets"><li>Chief Operating Officer Ophir Nave said the Citi funding shows Nebius can choose “when and how we raise capital.”&nbsp;</li><li>According to him, the loan supports the company’s near-term buildout, with larger financing still ahead.</li><li>He said the company has $40 billion in long-term customer contracts that could serve as collateral.&nbsp;</li></ul>Nebius (NBIS) shares dipped in morning trade on Thursday amid the broader market sell-off after the company announced it had secured a $3.5 billion senior secured facility from Citi.&nbsp;Chief Operating Officer Ophir Nave said it shows the Nvidia (NVDA)-backed company can choose “when and how we raise capital.” The loan supports the near-term buildout, he said, and larger financing is still ahead.“Sequencing our financing is how we optimize our long-term cost of capital,” Nave stated. “We still have a range of capital sources available to us to finance the next phase of growth.” He added that the company currently has $40 billion in long-term customer contracts that could be used for collateral.&nbsp;<a href="https://stocktwits.com/symbol/NBIS">NBIS stock</a> fell as much as 2.5% in pre-market trade and was among the top trending tickers on Stocktwits at the time of writing, with retail traders debating whether the new loan aids the company’s AI build out or increases debt risk.<h2 class="st-heading-2">Nebius Short-Term Funding&nbsp;</h2>The facility matures in 364 days and initially carries an interest rate of Term SOFR plus 2.75%, rising to a maximum of 3.50%, subject to other adjustments. Nebius said proceeds will go toward data center development, GPU purchases and general corporate purposes.&nbsp;However, the loan comes amid mounting pressure on the neocloud sector. Investors have become more cautious about the debt required to finance rapid expansion, with CoreWeave (CRWV) at the center of the recent market turmoil.<h2 class="st-heading-2">Neocloud Credit Concerns</h2>CoreWeave lost roughly a quarter of its market value last week during a sharp sell-off in its shares and bonds. Yields on some of its bonds climbed to around 15%, up from about 9.675% when the debt was issued last year.Both NBIS stock and CRWV shares have fallen nearly 30% this month amid the sell-off. Piper Sandler cut its price target on Nebius by 22% to $185 on Wednesday, warning that neocloud stocks could remain “in the penalty box” until the financing outlook becomes clearer. Gartner has predicted that more than 80% of neocloud providers will cease operating independently by 2030.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261022_080227281_f26c66e73d.png" alt="koyfin_20261022_080227281.png" width="2400" height="1240"><figcaption>NBIS, CRWV stocks price performance month-to-date on October 22, as of 8:00 a.m. ET. | Source: Kofyin</figcaption></figure>“We caught a lot of hate when we initiated CRWV with a $56 price target seven months ago,” Bernstein told CNBC on Thursday. “Today, it’s a lot harder to find bulls — certainly some of them just don’t call us anymore.” The firm reiterated its ‘Underweight’ rating on CoreWeave.&nbsp;<h2 class="st-heading-2">How Is Retail Feeling About NBIS Stock?</h2>On Stocktwits, retail sentiment around Nebius trended in ‘extremely bullish’ territory over the past day, accompanied by chatter at ‘extremely high’ levels. Platform data showed that message volume around the shares has more than doubled over the past week.<figure class="image"><img src="https://news.stocktwits-cdn.com/image_28_84d7e422d3.png" alt="image (28).png" width="1286" height="686"><figcaption>NBIS stock retail sentiment on October 22 as of 8:00 a.m. ET | Source: Stocktwits</figcaption></figure>One retail trader stated that although sentiment toward data center companies had deteriorated, Nebius remained one of the strongest businesses among major neocloud providers.&nbsp;<stembedurl>https://stocktwits.com/Bull4life24/message/667072469</stembedurl>Another trader said the Citi financing could help push NBIS shares back above $180. <stembedurl>https://stocktwits.com/Unusualtable/message/667093255</stembedurl>NBIS stock is still up 90% this year despite the recent AI selloff, which puts the shares over 70% below its record high of over $299 seen in June.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-jensen-huang-ai-chips-financeable-asset-neocloud-demand-is-off-the-charts/cZxw3N7RBwo">Nvidia’s Jensen Huang Wants AI Chips To Be A ‘Financeable Asset,’ Says Neocloud Demand Is ‘Off The Charts’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Nebius Group logo is seen displayed on a smartphone screen with a green circuit board in the background. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Nebius (NBIS) shares dipped in morning trade on Thursday amid the broader market sell-off after the company announced it had secured a $3.5 billion senior secured facility from Citi.

Nebius Secures $3.5B From Citi, Says Larger Asset-Backed Loans Are Still Ahead

Roundhill Generative AI & Technology ETF

CoreWeave Inc

Nebius Group N.V.

Invesco NASDAQ 100 ETF

First Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$292.87
Prev Close	$309.28
Open	$298.56
Dividend Yield	N/A
50-Day Moving Average	$316.43
Beta	N/A
Avg. Volume	256,571.31
PE Ratio	N/A

52-Week High	$342.51
52-Week Low	$205.57
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

QTEC Fundamentals